Small Cell Lung Cancer Limited Stage

Limited-stage small cell lung cancer is a type of lung cancer where the disease is confined to one area of the chest that can be treated with radiation therapy to a single area. Although small cell lung cancer is aggressive and fast-growing, limited-stage disease is potentially curable when found early and treated properly.

Table of contents

• What is Limited-Stage Small Cell Lung Cancer?
• How Common is This Condition?
• Classification and Staging Systems
• Signs and Symptoms
• How is it Diagnosed?
• Treatment Options
• Outlook and Survival

What is Limited-Stage Small Cell Lung Cancer?

Limited-stage small cell lung cancer means the cancer is contained in a single area on one side of the chest. The cancer can be treated with radiotherapy (radiation treatment) to just one area^[1]. This generally means the cancer is only in one lung and may be in nearby lymph nodes (small organs that help fight infection) on the same side of the chest, including those in the center of the chest or above the collar bone^[2].

Small cell lung cancer is a rare, fast-growing type of lung cancer. It differs from non-small cell lung cancer in several ways, including where it begins, how the cells look under a microscope, and how quickly it progresses^[4]. Small cell lung cancer usually begins in the major airways in the center of the chest that lead to the lungs^[4].

The key feature that defines limited-stage disease is that all the cancer can be encompassed within a single radiation treatment area^[3][6]. Unlike extensive-stage small cell lung cancer, limited-stage disease is potentially curable^[6][17].

How Common is This Condition?

Small cell lung cancer accounts for about 10% to 15% of all lung cancer diagnoses^[4][5]. Of the people diagnosed with small cell lung cancer, approximately 30% to 33% have limited-stage disease when it is first found^[3][4][6].

The overall incidence of small cell lung cancer has been decreasing over the past few decades, probably reflecting the declining rates of tobacco use^[11][12].

Classification and Staging Systems

Doctors use staging systems to describe how far cancer has spread in the body. For small cell lung cancer, two different staging approaches are commonly used^[2][8].

Two-Stage System

The simpler and older staging system divides small cell lung cancer into two categories: limited stage and extensive stage. This system was introduced by the Veterans’ Administration Lung Study Group in the 1950s^[6][17]. Healthcare providers often use this system because small cell lung cancer tends to spread early and is usually treated as a disease affecting the whole body rather than just one specific location^[6][17].

TNM Staging System

The American Joint Committee on Cancer now recommends using the TNM staging system for small cell lung cancer^[2]. TNM stands for Tumor, Node, and Metastasis. This system describes the size of the tumor, whether cancer has spread to nearby lymph nodes, and whether it has spread to distant parts of the body^[2].

In the TNM system, limited-stage disease generally corresponds to stages 1, 2, and 3^[2][8][13]. Some variability exists in how doctors classify the disease, particularly regarding the extent of pleural effusion (fluid buildup around the lungs) and lymph node involvement^[6][17].

Signs and Symptoms

Small cell lung cancer that hasn’t spread rarely causes symptoms in its early stages^[5][14]. When symptoms do appear, they may include^[5][14][17]:

• Persistent cough that doesn’t go away or gets worse over time
• Chest pain or discomfort
• Coughing up blood
• Shortness of breath or difficulty breathing
• Wheezing
• Hoarseness
• Fatigue (extreme tiredness)
• Loss of appetite
• Unexplained weight loss
• Facial swelling
• Swollen neck veins
• Recurrent respiratory infections such as pneumonia (lung infection) or bronchitis (inflammation of the airways)

Many of these symptoms are similar to other less serious conditions. Having one or more of these symptoms doesn’t necessarily mean you have small cell lung cancer. However, if you smoke or used to smoke and notice these types of symptoms, you should talk to a healthcare provider^[5][14].

In some cases, small cell lung cancer can cause nervous system problems, Cushing syndrome (a hormonal disorder), or SIADH (syndrome of inappropriate anti-diuretic hormone), which affects the body’s water balance^[6][17].

How is it Diagnosed?

Diagnosing limited-stage small cell lung cancer involves several steps. Healthcare providers use various tests to confirm the presence of cancer and determine how far it has spread^[7].

Imaging Tests

Doctors use imaging tests to look inside the chest and other parts of the body. Common imaging tests include^[5][7]:

• Chest X-rays
• CT scans (computed tomography scans), which create detailed three-dimensional images of the body
• MRI scans (magnetic resonance imaging), which use magnets and radio waves to create images
• PET scans (positron emission tomography), which help identify areas where cancer may have spread

Biopsy

A biopsy is the only way to confirm a diagnosis of lung cancer^[7]. During a biopsy, a doctor removes a small sample of tissue to examine under a microscope. The tissue sample can be obtained through various methods, including bronchoscopy (using a thin tube inserted through the airways) or needle biopsy^[5].

Other Tests

Additional tests may include blood tests and examination of sputum (mucus coughed up from the lungs). After the cancer is diagnosed, further tests help determine whether it has spread to other parts of the body, such as the brain, bones, or liver^[7][11].

Treatment Options

Treatment for limited-stage small cell lung cancer typically involves a combination of different approaches. The goal is to eliminate the cancer or control its growth for as long as possible^[10][16].

Chemotherapy and Radiation Therapy Combined

The standard treatment for limited-stage small cell lung cancer is concurrent chemoradiotherapy, which means chemotherapy and radiation therapy given at the same time^[2][12][16]. This combined approach is more effective than giving the treatments separately.

Chemotherapy uses drugs to kill cancer cells throughout the body. The most common chemotherapy combination includes two drugs: a platinum-based drug (cisplatin or carboplatin) and etoposide^[12][16]. These drugs are given through a vein, usually in cycles over several months.

Radiation therapy is usually started during the first or second cycle of chemotherapy^[2][12]. The radiation is directed at the cancer in the chest and nearby lymph nodes. Different radiation schedules may be used, but common approaches include treatments given once or twice daily over several weeks^[12].

Surgery

Surgery is rarely used for small cell lung cancer because the cancer has usually spread beyond the lung by the time it is diagnosed^[2][16]. However, in rare cases where the cancer is found at a very early stage as a small spot in the lung and hasn’t spread to lymph nodes, surgery may be an option^[2][16]. The surgical procedure typically removes a section of the lung containing the cancer, called a lobectomy^[2][16].

If surgery is performed, patients usually receive chemotherapy afterward and may also have radiation therapy^[2][16].

Prophylactic Cranial Irradiation

For patients who respond well to initial treatment, doctors may recommend prophylactic cranial irradiation, which is radiation therapy directed at the brain^[2][10][12]. This treatment is given to reduce the risk of cancer spreading to the brain in the future. It has been shown to improve survival in patients with limited-stage disease who have had a good response to chemotherapy and radiation therapy^[12][17].

Treatment Decisions

The specific treatment plan depends on several factors, including the exact location and extent of the cancer, the patient’s overall health, and personal preferences^[16]. Patients who are healthy enough are usually offered concurrent chemoradiotherapy^[2][16]. Those who cannot tolerate this intensive treatment may receive chemotherapy alone or lower doses of treatment^[16].

Outlook and Survival

Limited-stage small cell lung cancer is potentially curable, unlike extensive-stage disease^[6][17]. The outlook for patients has improved significantly over the years thanks to advances in treatment.

With modern combination chemotherapy and radiation therapy, the five-year survival rate for limited-stage small cell lung cancer is approximately 26%^[6][12][17]. This represents a substantial improvement compared to earlier eras when survival rates were much lower^[6][17].

The median overall survival time for patients with limited-stage disease is approximately 12 to 16 months^[17]. However, some patients live much longer. Long-term survival is possible, with some patients surviving for many years after treatment^[17].

Several factors can affect a person’s outlook, including their overall health, how well they respond to treatment, and whether the cancer returns after treatment^[7]. Healthcare providers can cure some people if the disease is found early^[5][14].

It’s important to remember that statistics about survival are averages based on large groups of people. Each person’s situation is unique, and survival times can vary widely. Your healthcare team can provide more specific information based on your individual circumstances^[7].